| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7020dcdbed732051a119c9d4839a90f2 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate |
1987-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1993-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baac17aab773108ae17c70d92e38dae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d140bbbc621256e4106712db8acf0cd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0bec75f3c85048b2a8fa2ff4a87d77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92484c679462452c0a1e486f9acbf093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_734fba3c880fefce15e268511e0b9b72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c7c6c16af690a22a7e0961c3900e5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcee184b4e65bba2c0e73664f08c42c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d7a7c87826f27fd826d8a5f5a9a7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_022c48a0bfb13287e9f9f555941cde4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b586e69259a884f094669d43b28d67c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca153ad4443526b67de1a27d4a262c2 |
| publicationDate |
1993-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-1805967-C |
| titleOfInvention |
Biologically active substance used against aids virus |
| abstract |
Usage: the invention relates to medicine, namely to the pharmaceutical industry, and relates to a biologically active substance against the AIDS virus. The aim of the invention is to enhance specific activity. SUMMARY OF THE INVENTION The use of a sum of phenolic compounds isolated from buckthorn leaves of buckthorn-like aqueous acetone and purified with chloroform and a mixture of chloroform with isopropanol as a biologically active substance against the AIDS virus. The beneficial effect is the manifestation of a pronounced activity against the AIDS virus in H9 cell culture compared with inoslex and thymosin. 1 tab. |
| priorityDate |
1987-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |